Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis.

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Immune cells secrete growth factors aiding neuronal survival and repair during multiple sclerosis (MS) relapses.
• Growth factors regulate synaptic plasticity, including long-term potentiation (LTP), crucial for restoring neuronal excitability and clinical recovery.
• Platelet-derived growth factor (PDGF) may be key in maintaining synaptic plasticity reserve to counteract MS-related deterioration.

Purpose of the Study:

• To investigate the role of PDGF in clinical recovery and adaptive neuroplasticity in relapsing-remitting MS (RR-MS) patients.
• To determine the correlation between PDGF concentrations and clinical recovery extent after an MS relapse.
• To examine the relationship between PDGF levels and LTP-like cortical plasticity.

Main Methods:

• Analysis of cerebrospinal fluid (CSF) PDGF concentrations in RR-MS patients.
• Assessment of clinical recovery following MS relapses.
• Exploration of LTP-like cortical plasticity using paired associative stimulation (PAS).

Main Results:

• A significant correlation was found between CSF PDGF levels and the extent of clinical recovery; higher PDGF correlated with fuller recovery.
• CSF PDGF concentrations strongly correlated with the amplitude of LTP-like cortical plasticity measured by PAS.
• CSF levels of other tested growth factors (FGF, G-CSF, GM-CSF) did not correlate with clinical recovery or plasticity.

Conclusions:

• PDGF plays a crucial role in promoting clinical recovery and adaptive neuroplasticity in RR-MS.
• PDGF-driven synaptic plasticity may attenuate the clinical impact of tissue damage in MS.
• CSF PDGF levels serve as a potential biomarker for recovery and neuroplasticity in MS.